These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 31083353)

  • 1. The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics.
    van Loben Sels JM; Green KY
    Viruses; 2019 May; 11(5):. PubMed ID: 31083353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.
    Debbink K; Donaldson EF; Lindesmith LC; Baric RS
    J Virol; 2012 Jan; 86(2):1214-26. PubMed ID: 22090110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Llama nanoantibodies with therapeutic potential against human norovirus diarrhea.
    Garaicoechea L; Aguilar A; Parra GI; Bok M; Sosnovtsev SV; Canziani G; Green KY; Bok K; Parreño V
    PLoS One; 2015; 10(8):e0133665. PubMed ID: 26267898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies.
    Crawford SE; Ajami N; Parker TD; Kitamoto N; Natori K; Takeda N; Tanaka T; Kou B; Atmar RL; Estes MK
    Clin Vaccine Immunol; 2015 Feb; 22(2):168-77. PubMed ID: 25428246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.
    Mahar JE; Donker NC; Bok K; Talbo GH; Green KY; Kirkwood CD
    J Virol; 2014 Feb; 88(4):1942-52. PubMed ID: 24284328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Resolution Mapping of Human Norovirus Antigens via Genomic Phage Display Library Selections and Deep Sequencing.
    Huang W; Soeung V; Boragine DM; Hu L; Prasad BVV; Estes MK; Atmar RL; Palzkill T
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
    Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
    PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.
    Lindesmith LC; Donaldson EF; Beltramello M; Pintus S; Corti D; Swanstrom J; Debbink K; Jones TA; Lanzavecchia A; Baric RS
    J Virol; 2014 Aug; 88(16):8826-42. PubMed ID: 24872579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions.
    Lochridge VP; Jutila KL; Graff JW; Hardy ME
    J Gen Virol; 2005 Oct; 86(Pt 10):2799-2806. PubMed ID: 16186235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope.
    Shiota T; Okame M; Takanashi S; Khamrin P; Takagi M; Satou K; Masuoka Y; Yagyu F; Shimizu Y; Kohno H; Mizuguchi M; Okitsu S; Ushijima H
    J Virol; 2007 Nov; 81(22):12298-306. PubMed ID: 17855545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
    Lindesmith LC; Debbink K; Swanstrom J; Vinjé J; Costantini V; Baric RS; Donaldson EF
    J Virol; 2012 Jan; 86(2):873-83. PubMed ID: 22090098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid.
    Parker TD; Kitamoto N; Tanaka T; Hutson AM; Estes MK
    J Virol; 2005 Jun; 79(12):7402-9. PubMed ID: 15919896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.
    Malm M; Tamminen K; Heinimäki S; Vesikari T; Blazevic V
    Vaccine; 2018 Jan; 36(4):484-490. PubMed ID: 29246474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a cross-reactive monoclonal antibody against Norovirus genogroups I, II, III and V.
    Li X; Zhou R; Tian X; Li H; Zhou Z
    Virus Res; 2010 Aug; 151(2):142-7. PubMed ID: 20417671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GII.4 Human Norovirus: Surveying the Antigenic Landscape.
    Mallory ML; Lindesmith LC; Graham RL; Baric RS
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30791623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Human Norovirus GII.3 Blockade Antibody Epitopes.
    Yi Y; Wang S; Wang X; Xiong P; Liu Q; Zhang C; Yin F; Huang Z
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Broadly Cross-Reactive Epitope in the Inner Shell of the Norovirus Capsid.
    Parra GI; Azure J; Fischer R; Bok K; Sandoval-Jaime C; Sosnovtsev SV; Sander P; Green KY
    PLoS One; 2013; 8(6):e67592. PubMed ID: 23805319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-amino-acid substitution in the P2 domain of VP1 of murine norovirus is sufficient for escape from antibody neutralization.
    Lochridge VP; Hardy ME
    J Virol; 2007 Nov; 81(22):12316-22. PubMed ID: 17804495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norovirus GII.4 strain antigenic variation.
    Lindesmith LC; Donaldson EF; Baric RS
    J Virol; 2011 Jan; 85(1):231-42. PubMed ID: 20980508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.